Activity of AC-262536:
AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator. Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as apartial agonist for the androgen receptor with a Ki of 5nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the anabolic action, but only around 27% of its potency as an androgen.

Restricted by website rules, unable to post more details. If you want to know more details, you can add my APP:+8618942921723